Copyright Reports & Markets. All rights reserved.

Global Gastrointestinal Stromal Tumor Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Stomach
    • 1.4.3 Small Intestine
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Gastrointestinal Stromal Tumor Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Specialized Cancer Treatment Centers
    • 1.5.5 Other End Users
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2015-2026)
  • 2.2 Global Gastrointestinal Stromal Tumor Growth Trends by Regions
    • 2.2.1 Gastrointestinal Stromal Tumor Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Gastrointestinal Stromal Tumor Historic Market Share by Regions (2015-2020)
    • 2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Gastrointestinal Stromal Tumor Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Gastrointestinal Stromal Tumor Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Gastrointestinal Stromal Tumor Players by Market Size
    • 3.1.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue (2015-2020)
    • 3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Gastrointestinal Stromal Tumor Market Concentration Ratio
    • 3.2.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2019
  • 3.3 Gastrointestinal Stromal Tumor Key Players Head office and Area Served
  • 3.4 Key Players Gastrointestinal Stromal Tumor Product Solution and Service
  • 3.5 Date of Enter into Gastrointestinal Stromal Tumor Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2015-2020)
  • 4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)
  • 5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Gastrointestinal Stromal Tumor Market Size (2015-2020)
  • 6.2 Gastrointestinal Stromal Tumor Key Players in North America (2019-2020)
  • 6.3 North America Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
  • 6.4 North America Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Gastrointestinal Stromal Tumor Market Size (2015-2020)
  • 7.2 Gastrointestinal Stromal Tumor Key Players in Europe (2019-2020)
  • 7.3 Europe Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
  • 7.4 Europe Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

8 China

  • 8.1 China Gastrointestinal Stromal Tumor Market Size (2015-2020)
  • 8.2 Gastrointestinal Stromal Tumor Key Players in China (2019-2020)
  • 8.3 China Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
  • 8.4 China Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Gastrointestinal Stromal Tumor Market Size (2015-2020)
  • 9.2 Gastrointestinal Stromal Tumor Key Players in Japan (2019-2020)
  • 9.3 Japan Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
  • 9.4 Japan Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Gastrointestinal Stromal Tumor Market Size (2015-2020)
  • 10.2 Gastrointestinal Stromal Tumor Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

11 India

  • 11.1 India Gastrointestinal Stromal Tumor Market Size (2015-2020)
  • 11.2 Gastrointestinal Stromal Tumor Key Players in India (2019-2020)
  • 11.3 India Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
  • 11.4 India Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Gastrointestinal Stromal Tumor Market Size (2015-2020)
  • 12.2 Gastrointestinal Stromal Tumor Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
  • 12.4 Central & South America Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Novartis
    • 13.1.1 Novartis Company Details
    • 13.1.2 Novartis Business Overview
    • 13.1.3 Novartis Gastrointestinal Stromal Tumor Introduction
    • 13.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2015-2020))
    • 13.1.5 Novartis Recent Development
  • 13.2 ​​Sun Pharmaceutical
    • 13.2.1 ​​Sun Pharmaceutical Company Details
    • 13.2.2 ​​Sun Pharmaceutical Business Overview
    • 13.2.3 ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction
    • 13.2.4 ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
    • 13.2.5 ​​Sun Pharmaceutical Recent Development
  • 13.3 Pfizer
    • 13.3.1 Pfizer Company Details
    • 13.3.2 Pfizer Business Overview
    • 13.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction
    • 13.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
    • 13.3.5 Pfizer Recent Development
  • 13.4 Bayer Aktiengesellschaft
    • 13.4.1 Bayer Aktiengesellschaft Company Details
    • 13.4.2 Bayer Aktiengesellschaft Business Overview
    • 13.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction
    • 13.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
    • 13.4.5 Bayer Aktiengesellschaft Recent Development
  • 13.5 NATCO Pharma
    • 13.5.1 NATCO Pharma Company Details
    • 13.5.2 NATCO Pharma Business Overview
    • 13.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction
    • 13.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
    • 13.5.5 NATCO Pharma Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Gastrointestinal Stromal Tumor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Stromal Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Novartis
    ​​Sun Pharmaceutical
    Pfizer
    Bayer Aktiengesellschaft
    NATCO Pharma
    ...

    Market segment by Type, the product can be split into
    Stomach
    Small Intestine
    Others
    Market segment by Application, split into
    Hospitals
    Clinics
    Specialized Cancer Treatment Centers
    Other End Users

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now